Brief: Pyc Therapeutics Says FY Loss Attributable A$13.9 Million
31/08/2022 24:16
Aug 31 (Reuters) - PYC Therapeutics PYC.AX :
* FY LOSS ATTRIBUTABLE A$13.9 MILLION VERSUS LOSS OF A$17.8
MILLION
* FY REVENUES FROM ORDINARY ACTIVITIES UP 496% TO A$16.1
MILLION
Source text for Eikon: ID:nASXSKW2Z
Further company coverage: PYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PYC Therapeutics
See all newsBrief: PYC Therapeutics Announces Grant Of Patents By The US Patent Office
Brief: PYC Therapeutics Appoints Chief Financial Officer
Australia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million